Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
10.70
-0.54 (-4.80%)
At close: Apr 14, 2026, 4:00 PM EDT
11.07
+0.37 (3.42%)
After-hours: Apr 14, 2026, 6:56 PM EDT
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.74 billion as of April 14, 2026. Its market cap has decreased by -33.05% in one year.
Market Cap
3.74B
Enterprise Value
4.09B
1-Year Change
-33.05%
Ranking
Category
Stock Price
$10.70
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.74B, an increase of 3,144.26%. That is a compound annual growth rate of 51.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 3.70B | 46.16% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 4.46B |
| Crinetics Pharmaceuticals | 4.13B |
| Ligand Pharmaceuticals | 4.09B |
| Spyre Therapeutics | 4.03B |
| NewAmsterdam Pharma Company | 4.00B |
| Viking Therapeutics | 3.97B |
| Structure Therapeutics | 3.86B |
| ACADIA Pharmaceuticals | 3.71B |